136 related articles for article (PubMed ID: 1571128)
1. Administration of a prostaglandin synthetase inhibitor associated with an increased immune cell infiltrate in squamous cell carcinoma of the head and neck.
Cross DS; Platt JL; Juhn SK; Bach FH; Adams GL
Arch Otolaryngol Head Neck Surg; 1992 May; 118(5):526-8. PubMed ID: 1571128
[TBL] [Abstract][Full Text] [Related]
2. Tumor infiltrating lymphocytes in squamous cell carcinoma of the head and neck: mechanisms of enhancement using prostaglandin synthetase inhibitors.
Cross DS; Platt JL; Juhn SK; Bach FH; Adams GL
Adv Exp Med Biol; 1997; 400B():1013-24. PubMed ID: 9547657
[TBL] [Abstract][Full Text] [Related]
3. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis.
Wolf GT; Hudson JL; Peterson KA; Miller HL; McClatchey KD
Otolaryngol Head Neck Surg; 1986 Sep; 95(2):142-52. PubMed ID: 2954014
[TBL] [Abstract][Full Text] [Related]
5. Immunostimulation of patients with head and neck cancer. In vitro and preliminary clinical experiences.
Hirsch B; Johnson JT; Rabin BS; Thearle PB
Arch Otolaryngol; 1983 May; 109(5):298-301. PubMed ID: 6847479
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
7. Head and neck squamous cell carcinoma cell line-induced suppression of in vitro lymphocyte proliferative responses.
Lapointe H; Lampe H; Banerjee D
Otolaryngol Head Neck Surg; 1992 Feb; 106(2):149-58. PubMed ID: 1738546
[TBL] [Abstract][Full Text] [Related]
8. Indomethacin sensitive suppressor-cell activity in head and neck cancer patients. The role of the adherent mononuclear cell.
Wanebo HJ; Riley T; Katz D; Pace RC; Johns ME; Cantrell RW
Cancer; 1988 Feb; 61(3):462-74. PubMed ID: 2962730
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.
Badoual C; Hans S; Rodriguez J; Peyrard S; Klein C; Agueznay Nel H; Mosseri V; Laccourreye O; Bruneval P; Fridman WH; Brasnu DF; Tartour E
Clin Cancer Res; 2006 Jan; 12(2):465-72. PubMed ID: 16428488
[TBL] [Abstract][Full Text] [Related]
10. Blockade of MCP-1/CCR4 signaling-induced recruitment of activated regulatory cells evokes an antitumor immune response in head and neck squamous cell carcinoma.
Sun W; Li WJ; Wei FQ; Wong TS; Lei WB; Zhu XL; Li J; Wen WP
Oncotarget; 2016 Jun; 7(25):37714-37727. PubMed ID: 27177223
[TBL] [Abstract][Full Text] [Related]
11. Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor.
Panje WR
Arch Otolaryngol; 1981 Nov; 107(11):658-63. PubMed ID: 7295159
[TBL] [Abstract][Full Text] [Related]
12. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
Nguyen N; Bellile E; Thomas D; McHugh J; Rozek L; Virani S; Peterson L; Carey TE; Walline H; Moyer J; Spector M; Perim D; Prince M; McLean S; Bradford CR; Taylor JM; Wolf GT;
Head Neck; 2016 Jul; 38(7):1074-84. PubMed ID: 26879675
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.
Bhattacharya S; Muhammad N; Steele R; Peng G; Ray RB
Oncotarget; 2016 May; 7(22):33202-9. PubMed ID: 27120805
[TBL] [Abstract][Full Text] [Related]
14. Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients.
Balch CM; Dougherty PA; Tilden AB
Ann Surg; 1982 Dec; 196(6):645-50. PubMed ID: 6216863
[TBL] [Abstract][Full Text] [Related]
15. Indomethacin sensitive suppressor cell activity in head and neck cancer patients pre- and postirradiation therapy.
Maca RD; Panje WR
Cancer; 1982 Aug; 50(3):483-9. PubMed ID: 7093891
[TBL] [Abstract][Full Text] [Related]
16. Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma.
Poropatich K; Hernandez D; Fontanarosa J; Brown K; Woloschak G; Paintal A; Raparia K; Samant S
J Oral Pathol Med; 2017 Nov; 46(10):972-978. PubMed ID: 28632936
[TBL] [Abstract][Full Text] [Related]
17. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
18. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
[TBL] [Abstract][Full Text] [Related]
19. The effect of prostaglandin and its inhibitor on antibody-dependent cellular cytotoxicity against human squamous cell carcinoma of head and neck.
Kim CD; Sung MW; Lee SJ; Heo DS; Yoon SJ; Kim KH
Anticancer Res; 1999; 19(1A):455-9. PubMed ID: 10226582
[TBL] [Abstract][Full Text] [Related]
20. Metformin Effects on FOXP3
Amin D; Richa T; Mollaee M; Zhan T; Tassone P; Johnson J; Luginbuhl A; Cognetti D; Martinez-Outschoorn U; Stapp R; Solomides C; Rodeck U; Curry J
Laryngoscope; 2020 Sep; 130(9):E490-E498. PubMed ID: 31593308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
